These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6360771)

  • 1. Experimental galactosemia produces diabetic-like retinopathy.
    Engerman RL; Kern TS
    Diabetes; 1984 Jan; 33(1):97-100. PubMed ID: 6360771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia as a cause of diabetic retinopathy.
    Engerman RL; Kern TS
    Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation in experimental diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Diabetes; 1984 Sep; 33(9):846-50. PubMed ID: 6381180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney morphology in experimental hyperglycemia.
    Kern TS; Engerman RL
    Diabetes; 1987 Feb; 36(2):244-9. PubMed ID: 3803734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated blood viscosity in alloxan diabetic dogs and experimentally galactosemic dogs.
    Kern TS; Engerman RL; Peterson CM
    J Diabet Complications; 1989; 3(3):158-62. PubMed ID: 2528559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
    Kowluru RA; Tang J; Kern TS
    Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.
    Kowluru RA; Engerman RL; Kern TS
    Curr Eye Res; 2000 Oct; 21(4):814-9. PubMed ID: 11120572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia.
    Engerman RL; Kern TS; Larson ME
    Metabolism; 1990 Jun; 39(6):638-40. PubMed ID: 2352480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
    Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
    Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamics in experimentally galactosemic dogs and diabetic dogs.
    Kern TS; Engerman RL
    Metabolism; 1991 May; 40(5):450-4. PubMed ID: 1902544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vessel changes in galactose-fed dogs.
    Kobayashi T; Kubo E; Takahashi Y; Kasahara T; Yonezawa H; Akagi Y
    Arch Ophthalmol; 1998 Jun; 116(6):785-9. PubMed ID: 9639449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.